Search
LB54640
go.drugbank.com/drugs/DB18331InvestigationalLB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.
Autologous pancreatic islets
go.drugbank.com/drugs/DB18521InvestigationalAutologous pancreatic islet therapy involves isolating the patient's own insulin-producing cells.
GSBR-1290
go.drugbank.com/drugs/DB18551InvestigationalGSBR-1290 is a small molecule agonist of the GLP-1 receptor.
APG-157
go.drugbank.com/drugs/DB18683InvestigationalNutraceuticalAPG-157 consists of zinflavonoids being investigated for the treatment of cancers.
Biropepimut-S
go.drugbank.com/drugs/DB14816InvestigationalBiropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral
alpha-N-Acetyl-D-galactosamine
go.drugbank.com/drugs/DB03567InvestigationalThe N-acetyl derivative of galactosamine. [PubChem]
Synonyms: Tn saccharide, Tn antigen saccharideSBT-100
go.drugbank.com/drugs/DB17215ExperimentalIt was granted orphan drug designation by the FDA for the treatment of pancreatic cancer and osteosarcoma.[L44131,L44136]
Enlonstobart
go.drugbank.com/drugs/DB21890Investigational[A274486] It targets the programmed cell death protein 1 (PD-1), is being developed by the CSPC Pharmaceutical Group for the treatment of advanced cervical cancer and other solid tumours.
Zeteletinib
go.drugbank.com/drugs/DB21491InvestigationalThe usage of the INN stem '-tinib' in the name indicates that Zeteletinib is a tyrosine kinase inhibitor.